CAMP and colonic neoplasm: To date, it has been reported that ceragenin CSA-13 and LL-37-derived peptides, FK-16 and FF/CAP18, inhibit colon cancer progression due to initiation of caspase-independent apoptosis in cancer cells and induction of cell cycle arrest [17, 28, 29].